Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10002892HBVENSG00000179097.7protein_codingHTR1FNoNo3355P30939
TVIS10022331HBVENSG00000179097.7protein_codingHTR1FNoNo3355P30939
TVIS10029333HBVENSG00000179097.7protein_codingHTR1FNoNo3355P30939
TVIS10045058HBVENSG00000179097.7protein_codingHTR1FNoNo3355P30939
TVIS20005969HPVENSG00000179097.7protein_codingHTR1FNoNo3355P30939
TVIS20008720HPVENSG00000179097.7protein_codingHTR1FNoNo3355P30939
TVIS20041792HPVENSG00000179097.7protein_codingHTR1FNoNo3355P30939
TVIS20022109HPVENSG00000179097.7protein_codingHTR1FNoNo3355P30939
TVIS20022108HPVENSG00000179097.7protein_codingHTR1FNoNo3355P30939
TVIS20056982HPVENSG00000179097.7protein_codingHTR1FNoNo3355P30939
TCGA Plot Options
Drug Information
GeneHTR1F
DrugBank IDDB11732
Drug NameLasmiditan
Target IDBE0000460
UniProt IDP30939
Regulation Typeagonist
PubMed IDs25584073
CitationsReuter U, Israel H, Neeb L: The pharmacological profile and clinical prospects of the oral 5-HT1F receptor agonist lasmiditan in the acute treatment of migraine. Ther Adv Neurol Disord. 2015 Jan;8(1):46-54. doi: 10.1177/1756285614562419.
GroupsApproved; Investigational
Direct Classification4-halobenzoic acids and derivatives
SMILESCN1CCC(CC1)C(=O)C1=CC=CC(NC(=O)C2=C(F)C=C(F)C=C2F)=N1
Pathways
PharmGKB
ChEMBLCHEMBL3039520